Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
171
days
Loss of EMILIN-1/integrin axis drives microenvironmental reprogramming in gastric tumorigenesis
Authors
Alessandra Capuano; Maddalena Vescovo; Samanta Muzzin; Enrica Timis; Laura Cesaratto; Eliana Pivetta; Roberto Doliana; Antonio Palumbo; Renato Cannizzaro; Vincenzo Canzonieri; Eugenio Scanziani; Simone Canesi; Gustavo Baldassarre; Maurizio Mongiat; Paola SpessottoShow moreShow less
Affiliations
1. Molecular Oncology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 2. Dipartimento Di Medicina, Università Degli Studi Di Udine, Udine, Italy; 3. Pathology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 4. Oncological Gastroenterology Unit, Centro Di Riferimento Oncologico Aviano, (CRO) IRCCS, Aviano, Italy; 5. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 6. Dipartimento Di Medicina Veterinaria E Scienze Animali (DIVAS), Università Degli Studi Di Milano, Milan, Italy; 7. Mouse & Animal Pathology Lab (MAPLab), Milan, ItalyShow moreShow less
163
days
Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)
Authors
Hidekazu Hirano; Yoichi Naito; Tsuyoshi Takahashi; Seiichi Hirota; Kyoung-Mee Kim; Min-Hee Ryu; Jian Wang; Hui Cao; Jian Li; Chien-Feng Li; Chueh-Chuan Yen; Han-Kwang Yang; Hwoon-Yong Jung; Chun-Nan Yeh; Hsiu-Po Wang; Li-Tzong Chen; Lin Shen; Yoon-Koo Kang; Toshirou NishidaShow moreShow less
Affiliations
1. Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 2. Department of General Internal Medicine/Experimental Therapeutics/Medical Oncology, National Cancer Center Hospital East, Chiba, Japan; 3. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan; 4. Department of Diagnostic Pathology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan; 5. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 6. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 7. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China; 8. Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 9. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Cell & Gene Therapy for Solid Tumor, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China; 10. National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 11. Division of Clinical Research, Department of Medical Research, and Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; 12. School of Medicine, College of Medicine, and Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan; 13. Department of Surgery, Seoul National University Hospital, Seoul, Republic of Korea; 14. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 15. Department of Surgery, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taipei, Taiwan; 16. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; 17. Department of Internal Medicine, Kaohsiung Medical University Hospital, and College of Medicine and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 18. Department of Oncology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si, Republic of Korea; 19. Department of Surgery, Japan Community Healthcare Organization Osaka Hospital, Fukushima-ku, Osaka, Japan; 20. Rare Cancer Center, National Cancer Center, Tokyo, JapanShow moreShow less
129
days
Germline whole-exome sequencing identifies CTNND1 as a candidate gene for hereditary gastric cancer in a large Brazilian cohort
Authors
Deivid Calebe de Souza; Thaliane Buranello; Dario Tenorio Tavares Neto; Janina Pontes Pisani; Giovanna Napolitano Pereira Ribeiro; Marcia Olandoski; David Schlesinger; João Paulo Kitajima; Danilo Vilela Viana; Maria Isabel AchatzShow moreShow less
Affiliations
1. Hospital Sírio-Libanês, São Paulo, Brazil; 2. Oncoclínicas Ribeirão Preto, Ribeirão Preto, Brazil; 3. Centro Universitário da Fundação Assis Gurgacz, Cascavel, Brazil; 4. Universidade Federal de São Paulo, São Paulo, Brazil; 5. Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; 6. Mendelics, São Paulo, BrazilShow moreShow less
3
days
Biomarker discordance in gastric cancer: from tissue snapshots to treatment-defining assays
Authors
Xiubi Zhang; Chaochi YueShow moreShow less
Affiliations
1. College of Integrative Chinese and Western Medicine, Southwest Medical University, Luzhou, People’s Republic of China; 2. Department of Traditional Chinese Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of ChinaShow moreShow less
34
days
Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma
Authors
Cecilie Riis Iden; Nadia Øgaard; Salah Mohammad Mustafa; Ida Coordt Elle; Mette Yilmaz; Marianne Nordsmark; Tenna Henriksen; Torben Kruse; Mads Thomassen; Per Pfeiffer; Claus Lindbjerg Andersen; Lene Bæksgaard; Camilla Qvortrup; Morten Mau-SørensenShow moreShow less
Affiliations
1. Department of Oncology, Copenhagen University Hospital, Rigshospitalet, København Ø, Denmark; 2. Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark; 3. Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus N, Denmark; 4. Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark; 5. Department of Oncology, University Hospital of Aalborg, Aalborg, Denmark; 6. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; 7. Clinical Genome Center, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 8. Department of Oncology, Odense University Hospital, Odense C, DenmarkShow moreShow less
149
days
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy
Authors
Changgon Kim; Junkyu Kim; Ji Eun Shin; Sung Hee Lim; Kyoung-Mee Kim; Deok Geun Kim; Jeeyun Lee; Seung Tae KimShow moreShow less
Affiliations
1. Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea; 2. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 3. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; 4. Department of Clinical Genomics Center, Samsung Medical Center, Seoul, South Korea; 5. Department of Digital Health, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, South KoreaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days